HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ron L Paquette Selected Research

Thrombopoietin (c-mpl Ligand)

10/2010Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ron L Paquette Research Topics

Disease

1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2010
1Thrombocytopenia (Thrombopenia)
10/2010
1Arthralgia (Joint Pain)
10/2010
1Exanthema (Rash)
10/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2003

Drug/Important Bio-Agent (IBA)

1Tyrosine Kinase InhibitorsIBA
01/2019
1Thrombopoietin (c-mpl Ligand)IBA
10/2010
1Azacitidine (5 Azacytidine)FDA Link
10/2010
1romiplostimFDA Link
10/2010
1Sunitinib (Sutent)FDA Link
11/2003

Therapy/Procedure

2Therapeutics
10/2010 - 11/2003
1Platelet Transfusion (Blood Platelet Transfusions)
10/2010